Wells Fargo
VERA icon

Wells Fargo’s Vera Therapeutics VERA Stock Holding History

Wells Fargo’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.31M Buy
147,086
+32,321
+28% +$1.2M ﹤0.01% 2623
2026
Q1 		$4.62M Sell
114,765
-30,440
-21% -$1.31M ﹤0.01% 2659
2025
Q4 		$7.35M Buy
145,205
+63,993
+79% +$2.27M ﹤0.01% 2316
2025
Q3 		$2.36M Buy
81,212
+47,368
+140% +$1.1M ﹤0.01% 3202
2025
Q2 		$797K Sell
33,844
-9,474
-22% -$213K ﹤0.01% 3843
2025
Q1 		$1.04M Buy
43,318
+3,742
+9% +$120K ﹤0.01% 3628
2024
Q4 		$1.67M Buy
39,576
+27,573
+230% +$1.22M ﹤0.01% 3333
2024
Q3 		$531K Sell
12,003
-475
-4% -$18K ﹤0.01% 3959
2024
Q2 		$451K Sell
12,478
-673
-5% -$26.7K ﹤0.01% 3978
2024
Q1 		$567K Buy
13,151
+3,519
+37% +$125K ﹤0.01% 3805
2023
Q4 		$148K Sell
9,632
-22,771
-70% -$289K ﹤0.01% 4654
2023
Q3 		$444K Buy
32,403
+18,960
+141% +$325K ﹤0.01% 3860
2023
Q2 		$216K Buy
13,443
+9,236
+220% +$83.4K ﹤0.01% 4542
2023
Q1 		$32.6K Buy
+4,207
New +$32.5K ﹤0.01% 5396
2022
Q4 		– Sell
-231
Closed -$5K – 7752
2022
Q3 		$5K Sell
231
-112
-33% -$2.1K ﹤0.01% 5932
2022
Q2 		$5K Sell
343
-2,612
-88% -$45.6K ﹤0.01% 6032
2022
Q1 		$69K Sell
2,955
-2,742
-48% -$59K ﹤0.01% 5507
2021
Q4 		$152K Buy
5,697
+5,650
+12,021% +$125K ﹤0.01% 5420
2021
Q3 		$1K Buy
47
+19
+68% +$340 ﹤0.01% 6808
2021
Q2 		$0 Buy
+28
New +$435 ﹤0.01% 7487

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wells Fargo's VERA Position: Q2 2026 in Review

Wells Fargo increased its Vera Therapeutics (VERA) stake by 28% in Q2 2026, buying an estimated $1.2M and bringing the position to 147,086 shares worth $6.31M. The position accounts for ﹤0.01% of the portfolio, ranked #2623.

Wells Fargo first reported a position in VERA in Q2 2021 and has held it in 20 quarters since. The position peaked at $7.35M in Q4 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Wells Fargo held 147,086 shares of Vera Therapeutics worth $6.31M as of Q2 2026.
  • Wells Fargo bought 32,321 Vera Therapeutics shares in Q2 2026, an estimated $1.2M.
  • Vera Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #2623 holding.
  • Wells Fargo first reported a position in Vera Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • Wells Fargo's Vera Therapeutics position peaked at $7.35M in Q4 2025.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.